Similar articles

• Neoadjuvant treatment of oesophageal adenocarcinoma.

  Robb WB, Naughton P, Walsh TN. Robb WB, et al. Minerva Chir. 2004 Oct;59(5):461-70. Minerva Chir. 2004. PMID: 15494673 Review.
• [Preoperative chemoradiation in esophageal cancer: experience of a single center in 102 patients].

  Imdahl A, Schöffel U, Ruf G, Hopf UT. Imdahl A, et al. Zentralbl Chir. 2004 Oct;129(5):350-5. doi: 10.1055/s-2004-820389. Zentralbl Chir. 2004. PMID: 15486784 German.
• [No improvement of prognosis by neoadjuvant chemotherapy alone in operable esophageal carcinoma].

  Fietkau R. Fietkau R. Strahlenther Onkol. 1999 May;175(5):251-2. doi: 10.1007/BF02742406. Strahlenther Onkol. 1999. PMID: 10356618 Clinical Trial. German. No abstract available.
• Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.

  Pennathur A, Luketich JD, Landreneau RJ, Ward J, Christie NA, Gibson MK, Schuchert M, Cooper K, Land SR, Belani CP. Pennathur A, et al. Ann Thorac Surg. 2008 Jun;85(6):1930-6; discussion 1936-7. doi: 10.1016/j.athoracsur.2008.01.097. Ann Thorac Surg. 2008. PMID: 18498797 Clinical Trial.
• Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.

  Mariette C, Taillier G, Van Seuningen I, Triboulet JP. Mariette C, et al. Ann Thorac Surg. 2004 Oct;78(4):1177-83. doi: 10.1016/j.athoracsur.2004.02.068. Ann Thorac Surg. 2004. PMID: 15464466 Review.